JR

Jean-Christophe Renauld

LR Ludwig Institute For Cancer Research: 27 patents #14 of 611Top 3%
Pfizer: 4 patents #1,262 of 5,153Top 25%
UL Université Catholique De Louvain: 3 patents #16 of 203Top 8%
AB Argenx Bvba: 2 patents #13 of 34Top 40%
ML Medimmune Limited: 1 patents #469 of 738Top 65%
📍 Kraainem, BE: #2 of 54 inventorsTop 4%
Overall (All Time): #107,285 of 4,157,543Top 3%
33
Patents All Time

Issued Patents All Time

Showing 26–33 of 33 patents

Patent #TitleCo-InventorsDate
5843688 Isolated tyrosinase derived peptides and uses thereof Thomas Wolfel, Aline Van Pel, Vincent Brichard, Thierry Boon-Falleur, Etienne DePlaen +2 more 1998-12-01
5830454 Method for treating cell mediated autoimmune disorders using interleukin-9 Mary-Christine Many 1998-11-03
5824551 Method for modulating cell apoptosis Jo Van Damme, Paul Proost, Frédéric Houssiau 1998-10-20
5789237 Nucleic acid sequences coding for or complementary to nucleic acid sequences coding for interleukin 9 receptor Catherine Druez, Jacques Van Snick 1998-08-04
5571711 Isolated nucleic acid molecules coding for BAGE tumor rejection antigen precursors Pierre van der Bruggen, Thierry Boon-Falleur, Pierre Coulie 1996-11-05
5530096 Isolated, tyrosinase derived peptides and uses thereof Thomas Wolfel, Aline Van Pel, Vincent Brichard, Thierry Boon-Falleur, Etienne DePlaen +2 more 1996-06-25
5246701 Method for inhibiting production of IgE by using IL-9 inhibitors Bernard Dugas, Catherine Druez, Pierre Braquet, Jean M. Mencia-Huerta, Catherine Uyttenhove +1 more 1993-09-21
5132109 Method for inhibiting production of IGE and method for enhancing production of IGG using interleukin 9 and inhibitors thereof Bernard Dugas, Catherine Druez, Pierre Braquet, Jean M. Mencia-Huerta, Catherine Uyttenhove +1 more 1992-07-21